A new small open-label study on ubiquinol was recently published and shows some promise for those with diabetes. This study focused on type 2 diabetics receiving conventional medication, who also received an oral dose of 200 mg ubiquinol daily for 12 weeks. 5 healthy controls were also assigned to receive an oral dose of 200 mg ubiquinol daily for 4 weeks to examine the effects of ubiquinol on insulin secretion.
Another study shows L-carnitine can improve symptoms in autism. Experts in the field believe that autism is influenced by a combination of genetic, environmental and immunological factors. New evidence has suggested that autistic patients show increased vulnerability to oxidative stress coupled with mitochondrial dysfunction, which is confirmed by altered brain energy metabolism, lowered cellular energetic and deficient reserve mitochondrial energy capacity.
Since L-carnitine is essential in transporting the main source of the body's energy (long fatty acids) to the mitochondria, therapy with this amino acid has shown to be useful (as I discussed in THIS post from last year).